Get the Stockscreener App
2.75
4.84%
-0.14
After Hours:
2.75
Nuvation Bio Inc stock is traded at $2.75, with a volume of 3.21M.
It is down -4.84% in the last 24 hours and up +20.09% over the past month.
See More
Previous Close:
$2.89
Open:
$2.9
24h Volume:
3.21M
Relative Volume:
1.69
Market Cap:
$925.56M
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-6.7073
EPS:
-0.41
Net Cash Flow:
$-68.07M
1W Performance:
-4.84%
1M Performance:
+20.09%
6M Performance:
+5.36%
1Y Performance:
+108.33%
1-Day Range:
$2.725
$2.93
1-Week Range:
$2.725
$3.05
52-Week Range:
$1.27
$4.1598
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.75 | 925.56M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.98 | 119.49B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.26 | 82.89B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
624.96 | 37.37B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.72 | 32.85B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
114.70 | 27.50B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Nuvation Bio’s Q3 2024 Highlights and Future Prospects - TipRanks
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - Simply Wall St
Nuvation Bio (NYSE:NUVB) Shares Down 7.7%Time to Sell? - MarketBeat
Nuvation Bio's SWOT analysis: taletrectinib drives stock potential amid challenges - Investing.com India
FMR LLC Bolsters Stake in Nuvation Bio Inc - GuruFocus.com
Nuvation Bio to Present at the Jefferies London Healthcare Conference - Business Wire
What is Wedbush's Estimate for Nuvation Bio FY2024 Earnings? - MarketBeat
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat
Nuvation Bio’s Global Challenges: Navigating Risks in China Amid Geopolitical Tensions - TipRanks
Royal Bank of Canada Increases Nuvation Bio (NYSE:NUVB) Price Target to $6.00 - MarketBeat
Nuvation Bio reports Q3 EPS (15c, consensus (13c) - TipRanks
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline - Yahoo Finance
11 Best NYSE Penny Stocks to Buy Right Now - Insider Monkey
Nuvation Bio (NYSE:NUVB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Update - MarketBeat
Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3%What's Next? - MarketBeat
Wedbush Analysts Boost Earnings Estimates for Nuvation Bio - MarketBeat
What is Wedbush's Forecast for Nuvation Bio FY2028 Earnings? - MarketBeat
Nuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from Wedbush - MarketBeat
Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market (NYSE:NUVB) - Seeking Alpha
Financial Survey: Neoleukin Therapeutics (NASDAQ:NLTX) & Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.8%Time to Sell? - MarketBeat
This Biotech Stock Insider is Buying Shares, Should You? - Inkl
This Biotech Stock Insider Is Buying Shares, Should You? - Barchart
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? - Insider Monkey
Robert Mashal Spends US$220k On Nuvation Bio Shares - Simply Wall St
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k - Yahoo Finance
Is Nuvation Bio Inc (NUVB) a opportunity to investors? - US Post News
The Attractiveness of Investing In Nuvation Bio Inc (NUVB) is Growing - Knox Daily
Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock? - Insider Monkey
Trading Day Review: Nuvation Bio Inc (NUVB) Gains Momentum, Closing at 2.27 - The Dwinnex
The Significance of Moving Averages in Nuvation Bio Inc Inc. (NUVB) Price Performance - The InvestChronicle
Nuvation Bio (NYSE:NUVB) Trading Up 10.4% Following Insider Buying Activity - MarketBeat
Nuvation Bio director acquires $220k in company stock By Investing.com - Investing.com South Africa
Dimensional Fund Advisors LP Boosts Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Insider Buying: Nuvation Bio Inc. (NYSE:NUVB) Director Acquires 100,000 Shares of Stock - MarketBeat
Nuvation Bio director acquires $220k in company stock - Investing.com
Director Cui Xiangmin acquire 277,895 shares of Nuvation Bio Inc [NUVB] - Knox Daily
Views of Wall Street’s Leading Experts on Nuvation Bio Inc - SETE News
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.4%Here's What Happened - MarketBeat
Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 - Insider Monkey
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
3.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):